Case Report

Bilateral Synchronous Carcinoma of the Male Breast in a Patient Receiving Estrogen Therapy for Carcinoma of the Prostate: Cause or Coincidence?

Authors: Kathleen Coard, DM(PATH), Trevor McCartney, DM(SURG), FRCS(EDIN)

Abstract

An unusual case of bilateral, synchronous breast cancer in a male patient who had a history of long-term estrogen therapy for prostate cancer is presented. The possible role of estrogen in the development of male breast cancer is revisited.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Crichlow RW, Galt SW. Male breast cancer. Surg Clin North Am 1990; 70: 1165–1177.
 
2. Hanchard B, Blake G, Wolff C, Samuels E, Waugh N, Simpson D, et al. Age-specific incidence of cancer in Kingston and St Andrew, Jamaica, 1993–1997. West Indian Med J 2001; 50: 123–129.
 
3. Sasco AJ, Lowenfels AB, Pasker-de Jong P. Review article: Epidemiology of male breast cancer: A meta-analysis of published case-control studies and discussion of selected etiological factors. Int J Cancer 1993; 53: 538–549.
 
4. D’Avanzo B, La Vecchia C. Risk factors for male breast cancer. Br J Cancer 1995; 71: 1359–1362.
 
5. Rosenblatt KA, Thomas DB, McTiernan A, Austin MA, Stalsberg H, Stemhagen A, et al. Breast cancer in men: Aspects of familial aggregation. J Natl Cancer Inst 1991; 83: 849–854.
 
6. Tavassoli FA. Male breast lesions, in Pathology of the Breast. Stamford, CT, Appleton & Lange, 1999, ed 2, pp 837–844.
 
7. Scheike O, Visfeldt J, Petersen B. Male breast cancer: Part 3—Breast carcinoma in association with the Klinefelter syndrome. Acta Pathol Microbiol Scand [A] 1973; 81: 352–358.
 
8. Mabuchi K, Bross DS, Kessler II. Risk factors for male breast cancer. J Natl Cancer Inst 1985; 74: 371–375.
 
9. Hsing AW, McLaughlin JK, Cocco P, Co Chien HT, Fraumeni JF Jr. Risk factors for male breast cancer (United States). Cancer Causes Control 1998; 9: 269–275.
 
10. El-Gazayerli MM, Abdel-Aziz AS. On bilharziasis and male breast cancer in Egypt: A preliminary report and review of literature. Br J Cancer 1963; 17: 566–571.
 
11. Olsson H, Ranstam J. Head trauma and exposure to prolactin-elevating drugs as risk factors for male breast cancer. J Natl Cancer Inst 1988; 80: 679–683.
 
12. Karamanakos P, Apostolopoulos V, Fafouliotis S, Mela A, Ziounas Y, Trafalis DT. Synchronous bilateral primary male breast carcinoma with hyperprolactinemia. Acta Oncol 1996; 35: 757–759.
 
13. Volm MD, Talamonti MS, Thangavelu M, Gradishar WK. Pituitary adenoma and bilateral male breast cancer: An unusual association. J Surg Oncol 1997; 64: 74–78.
 
14. Thomas DB, Jimenez LM, McTiernan A, Rosenblatt K, Stalsberg H, Stemhagen A, et al. Breast cancer in men: Risk factors with hormonal implications. Am J Epidemiol 1992; 135: 734–748.
 
15. McClure JA, Higgins CC. Bilateral carcinoma of the male breast after estrogen therapy. JAMA 1951; 146: 7–9.
 
16. O’Grady WP, McDivitt RW. Breast cancer in a man treated with diethylstilbestrol. Arch Pathol 1969; 88: 162–165.
 
17. Schlappack OK, Braun O, Maier U. Report of two cases of male breast cancer after prolonged estrogen treatment for prostatic carcinoma. Cancer Detect Prev 1986; 9: 319–322.
 
18. Wilson SE, Hutchinson WB. Breast masses in males with carcinoma of the prostate. J Surg Oncol 1976; 8: 105–112.
 
19. Carlsson G, Hafstrom L, Jonsson PE. Male breast cancer. Clin Oncol 1981; 7: 149–155.
 
20. Symmers WS. Carcinoma of breast in transsexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics. Br Med J 1968; 2: 82–85.
 
21. Ganly I, Taylor EW. Breast cancer in a transsexual man receiving hormone replacement therapy. Br J Surg 1995; 82: 341.
 
22. Crichlow RW. Carcinoma of the male breast. Surg Gynecol Obstet 1972; 134: 1011–1019.
 
23. Friedman MA, Hoffman PG Jr, Dandolos EM, Lagios MD, Johnston WH, Siiteri PK. Estrogen receptors in male breast cancer: Clinical and pathologic correlations. Cancer 1981; 47: 134–137.